These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 1394642)
1. Effect of cyclodextrins on biological membrane. II. Mechanism of enhancement on the intestinal absorption of non-absorbable drug by cyclodextrins. Nakanishi K; Nadai T; Masada M; Miyajima K Chem Pharm Bull (Tokyo); 1992 May; 40(5):1252-6. PubMed ID: 1394642 [TBL] [Abstract][Full Text] [Related]
2. Effect of cyclodextrins on biological membrane. I. Effect of cyclodextrins on the absorption of a non-absorbable drug from rat small intestine and rectum. Nakanishi K; Nadai T; Masada M; Miyajima K Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1684-7. PubMed ID: 2208383 [TBL] [Abstract][Full Text] [Related]
3. Release characteristics of endogenous constituents by exposure of small intestine to modified beta-cyclodextrins. Tanino T; Ogiso T; Iwaki M; Yamaguchi T; Kakehi K Biol Pharm Bull; 1999 Oct; 22(10):1099-105. PubMed ID: 10549863 [TBL] [Abstract][Full Text] [Related]
4. Enhanced rectal absorption and reduced local irritation of the anti-inflammatory drug ethyl 4-biphenylylacetate in rats by complexation with water-soluble beta-cyclodextrin derivatives and formulation as oleaginous suppository. Arima H; Kondo T; Irie T; Uekama K J Pharm Sci; 1992 Nov; 81(11):1119-25. PubMed ID: 1447717 [TBL] [Abstract][Full Text] [Related]
5. Absorption enhancement of polypeptide drugs by cyclodextrins. I. Enhanced rectal absorption of insulin from hollow-type suppositories containing insulin and cyclodextrins in rabbits. Watanabe Y; Matsumoto Y; Seki M; Takase M; Matsumoto M Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3042-7. PubMed ID: 1477920 [TBL] [Abstract][Full Text] [Related]
6. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats. Arima H; Yunomae K; Miyake K; Irie T; Hirayama F; Uekama K J Pharm Sci; 2001 Jun; 90(6):690-701. PubMed ID: 11357172 [TBL] [Abstract][Full Text] [Related]
7. Enhancing effect of cyclodextrins on nasal absorption of insulin and its duration in rabbits. Watanabe Y; Matsumoto Y; Kawamoto K; Yazawa S; Matsumoto M Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3100-4. PubMed ID: 1477928 [TBL] [Abstract][Full Text] [Related]
8. Effect of sugar-modified beta-cyclodextrins on dissolution and absorption characteristics of phenytoin. Tanino T; Ogiso T; Iwaki M Biol Pharm Bull; 1999 Mar; 22(3):298-304. PubMed ID: 10220288 [TBL] [Abstract][Full Text] [Related]
9. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus. Arima H; Yunomae K; Hirayama F; Uekama K J Pharmacol Exp Ther; 2001 May; 297(2):547-55. PubMed ID: 11303042 [TBL] [Abstract][Full Text] [Related]
10. Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-beta-cyclodextrin, not 2,6-di-O-methyl-alpha-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells. Motoyama K; Kameyama K; Onodera R; Araki N; Hirayama F; Uekama K; Arima H Eur J Pharm Sci; 2009 Oct; 38(3):249-61. PubMed ID: 19664706 [TBL] [Abstract][Full Text] [Related]
11. [Use of water-soluble beta-cyclodextrin derivatives as carriers of anti-inflammatory drug biphenylylacetic acid in rectal delivery]. Arima H; Kondo T; Irie T; Hirayama F; Uekama K; Miyaji T; Inoue Y Yakugaku Zasshi; 1992 Jan; 112(1):65-72. PubMed ID: 1578346 [TBL] [Abstract][Full Text] [Related]
12. Possible enhancing mechanism of the cutaneous permeation of 4-biphenylylacetic acid by beta-cyclodextrin derivatives in hydrophilic ointment. Arima H; Miyaji T; Irie T; Hirayama F; Uekama K Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):582-6. PubMed ID: 8882455 [TBL] [Abstract][Full Text] [Related]
13. A study of the percutaneous absorption-enhancing effects of cyclodextrin derivatives in rats. Vollmer U; Müller BW; Peeters J; Mesens J; Wilffert B; Peters T J Pharm Pharmacol; 1994 Jan; 46(1):19-22. PubMed ID: 8201522 [TBL] [Abstract][Full Text] [Related]
14. Experimental, molecular docking investigations and bioavailability study on the inclusion complexes of finasteride and cyclodextrins. Mady FM; Farghaly Aly U Drug Des Devel Ther; 2017; 11():1681-1692. PubMed ID: 28652706 [TBL] [Abstract][Full Text] [Related]
15. A moderate interaction of maltosyl-alpha-cyclodextrin with Caco-2 cells in comparison with the parent cyclodextrin. Ono N; Arima H; Hirayama F; Uekama K Biol Pharm Bull; 2001 Apr; 24(4):395-402. PubMed ID: 11305602 [TBL] [Abstract][Full Text] [Related]
16. Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers. Sharma P; Varma MV; Chawla HP; Panchagnula R Farmaco; 2005; 60(11-12):884-93. PubMed ID: 16226752 [TBL] [Abstract][Full Text] [Related]
17. Some pharmaceutical properties of 3-hydroxypropyl- and 2,3-dihydroxypropyl-beta-cyclodextrins and their solubilizing and stabilizing abilities. Yoshida A; Yamamoto M; Irie T; Hirayama F; Uekama K Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):1059-63. PubMed ID: 2766408 [TBL] [Abstract][Full Text] [Related]
18. Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro. Irie T; Otagiri M; Sunada M; Uekama K; Ohtani Y; Yamada Y; Sugiyama Y J Pharmacobiodyn; 1982 Sep; 5(9):741-4. PubMed ID: 7153847 [TBL] [Abstract][Full Text] [Related]
19. Differential effects of modified beta-cyclodextrins on pharmacological activity and bioavailability of 4-biphenylacetic acid in rats after oral administration. Puglisi G; Ventura CA; Spadaro A; Campana G; Spampinato S J Pharm Pharmacol; 1995 Feb; 47(2):120-3. PubMed ID: 7602465 [TBL] [Abstract][Full Text] [Related]
20. Enhanced absorption of cyclosporin A by complexation with dimethyl-beta-cyclodextrin in bile duct-cannulated and -noncannulated rats. Miyake K; Arima H; Irie T; Hirayama F; Uekama K Biol Pharm Bull; 1999 Jan; 22(1):66-72. PubMed ID: 9989664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]